Ammonaps - Sodium phenylbutyrate
Active Ingredient: Sodium phenylbutyrate
Manufacturer: Immedica Pharma
Therapeutic area: Chronic management of urea cycle
Indication: Adjunctive therapy in the chronic management of urea cycle disorders, involving deficiencies of carbamylphosphate synthetase, ornithine transcarbamylase or argininosuccinate synthetase
Dosage: 500 mg
Size: Pack of 250 tablets
Temperature: Controlled room temperature